Enhanced proliferation and altered calcium handling in RGS2-deficient vascular smooth muscle cells

References

• Bridges TM, Lindsley CW. G-protein-coupled receptors: from classical modes of modulation to allosteric mechanisms. ACS Chem Biol 2008;3:530–41
   PubMed Web of Science ®Google Scholar
• Wang G, Wu G. Small GTPase regulation of GPCR anterograde trafficking. Trends Pharmacol Sci 2012;33:28–34
   PubMed Web of Science ®Google Scholar
• Trenkwalder P. Combination therapy with AT(1)-receptor blockers. J Hum Hypertens 2002;16:S17–25
   PubMedGoogle Scholar
• Mulvany MJ. Small artery remodeling in hypertension. Curr Hypertens Rep 2002;4:49–55
   PubMed Web of Science ®Google Scholar
• Wieland T, Mittmann C. Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system. Pharmacol Ther 2003;97:95–115
   Web of Science ®Google Scholar
• Gu S, Cifelli C, Wang S, Heximer SP. RGS proteins: identifying new GAPs in the understanding of blood pressure regulation and cardiovascular function. Clin Sci (Lond) 2009;116:391–9
   PubMed Web of Science ®Google Scholar
• Zhang P, Mende U. Functional role, mechanisms of regulation, and therapeutic potential of regulator of G protein signaling 2 in the heart. Trends Cardiovasc Med 2013;24:85–93
   Google Scholar
• Hercule HC, Tank J, Plehm R, et al. Regulator of G protein signalling 2 ameliorates angiotensin II-induced hypertension in mice. Exp Physiol 2007;92:1014–22
   PubMedGoogle Scholar
• Heximer SP, Knutsen RH, Sun X, et al. Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest 2003;111:445–52
   PubMed Web of Science ®Google Scholar
• Sun X, Kaltenbronn KM, Steinberg TH, Blumer KJ. RGS2 is a mediator of nitric oxide action on blood pressure and vasoconstrictor signaling. Mol Pharmacol 2005;67:631–9
   PubMed Web of Science ®Google Scholar
• Tang KM, Wang GR, Lu P, et al. Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med 2003;9:1506–12
   PubMed Web of Science ®Google Scholar
• Boelte KC, Gordy LE, Joyce S, et al. Rgs2 mediates pro-angiogenic function of myeloid derived suppressor cells in the tumor microenvironment via upregulation of MCP-1. PLoS One 2011;6:e18534
   Web of Science ®Google Scholar
• Hendriks-Balk MC, Hajji N, van Loenen PB, et al. Sphingosine-1-phosphate regulates RGS2 and RGS16 mRNA expression in vascular smooth muscle cells. Eur J Pharmacol 2009;606:25–31
   Google Scholar
• Husain M, Bein K, Jiang L, et al. c-Myb-dependent cell cycle progression and Ca2+ storage in cultured vascular smooth muscle cells. Circ Res 1997;80:617–26
   Google Scholar
• Husain M, Jiang L, See V, et al. Regulation of vascular smooth muscle cell proliferation by plasma membrane Ca(2+)-ATPase. Am J Physiol 1997;272:C1947–59
   Google Scholar
• Afroze T, Husain M. c-Myb-binding sites mediate G(1)/S-associated repression of the plasma membrane Ca(2+)-ATPase-1 promoter. J Biol Chem 2000;275:9062–9
   Google Scholar
• Afroze T, Yang LL, Wang C, et al. Calcineurin-independent regulation of plasma membrane Ca2+ ATPase-4 in the vascular smooth muscle cell cycle. Am J Physiol Cell Physiol 2003;285:C88–95
   Google Scholar
• Afroze T, Sadi AM, Momen MA, et al. c-Myb-dependent inositol 1,4,5-trisphosphate receptor type-1 expression in vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2007;27:1305–11
   Google Scholar
• Wang Y, Chen J, Wang Y, et al. Crucial role of type 1, but not type 3, inositol 1,4,5-trisphosphate (IP(3)) receptors in IP(3)-induced Ca(2+) release, capacitative Ca(2+) entry, and proliferation of A7r5 vascular smooth muscle cells. Circ Res 2001;88:202–9
   Google Scholar
• Choi J, Chiang A, Taulier N, et al. A calmodulin-binding site on cyclin E mediates Ca2+-sensitive G1/s transitions in vascular smooth muscle cells. Circ Res 2006;98:1273–81
   PubMed Web of Science ®Google Scholar
• Gros R, Afroze T, You XM, et al. Plasma membrane calcium ATPase overexpression in arterial smooth muscle increases vasomotor responsiveness and blood pressure. Circ Res 2003;93:614–21
   PubMed Web of Science ®Google Scholar
• Schuh K, Quaschning T, Knauer S, et al. Regulation of vascular tone in animals overexpressing the sarcolemmal calcium pump. J Biol Chem 2003;278:41246–52
   Google Scholar
• Oliveira-Dos-Santos AJ, Matsumoto G, Snow BE, et al. Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci USA 2000;97:12272–7
   PubMedGoogle Scholar
• Cornwell TL, Lincoln TM. Regulation of intracellular Ca2+ levels in cultured vascular smooth muscle cells. Reduction of Ca2+ by atriopeptin and 8-bromo-cyclic GMP is mediated by cyclic GMP-dependent protein kinase. J Biol Chem 1989;264:1146–55
   PubMed Web of Science ®Google Scholar
• Heximer SP, Srinivasa SP, Bernstein LS, et al. G protein selectivity is a determinant of RGS2 function. J Biol Chem 1999;274:34253–9
   PubMed Web of Science ®Google Scholar
• Kolodziejska KM, Noyan-Ashraf MH, Nagy A, et al. c-Myb-dependent smooth muscle cell differentiation. Circ Res 2008;102:554–61
   Google Scholar
• Afroze T, Yang G, Khoshbin A, et al. Calcium efflux activity of plasma membrane Ca2+ ATPase-4 (PMCA4) mediates cell cycle progression in vascular smooth muscle cells. J Biol Chem 2014;289:7221–31
   Google Scholar
• Wang X, Huang G, Luo X, et al. Role of regulator of G protein signaling 2 (RGS2) in Ca(2+) oscillations and adaptation of Ca(2+) signaling to reduce excitability of RGS2−/− cells. J Biol Chem 2004;279:41642–9
   Google Scholar
• Salim S, Sinnarajah S, Kehrl JH, Dessauer CW. Identification of RGS2 and type V adenylyl cyclase interaction sites. J Biol Chem 2003;278:15842–9
   Google Scholar
• Schoeber JP, Topala CN, Wang X, et al. RGS2 inhibits the epithelial Ca2+ channel TRPV6. J Biol Chem 2006;281:29669–74
   Google Scholar
• Heo K, Ha SH, Chae YC, et al. RGS2 promotes formation of neurites by stimulating microtubule polymerization. Cell Signal 2006;18:2182–92
   Google Scholar